Clinical Trial: Outpatient Administration of Teclistamab for Multiple Myeloma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Multiple Myeloma
Study Type: INTERVENTIONAL
Official Title: A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myeloma Patients
Brief Summary:
This is a phase II study to evaluate the Outpatient Administration of Teclistamab in Multiple Myeloma Patients
Read more